Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Celularity ( (CELU) ) has issued an update.
On May 20, 2025, Celularity Inc. entered into a letter agreement with YA II PN, Ltd. to extend the maturity date of a Convertible Promissory Note from May 12, 2025, to August 15, 2025. In exchange, Celularity issued 100,000 shares of restricted common stock to YA, which will have piggyback registration rights for resale in future registration statements filed by the company.
Spark’s Take on CELU Stock
According to Spark, TipRanks’ AI Analyst, CELU is a Neutral.
Celularity’s stock score is primarily impacted by its financial performance, characterized by strong revenue growth but ongoing profitability challenges and high leverage. Technical analysis indicates a positive short-term momentum, but the stock is below key long-term moving averages. The valuation is impacted by negative earnings and no dividend yield.
To see Spark’s full report on CELU stock, click here.
More about Celularity
Average Trading Volume: 123,822
Technical Sentiment Signal: Sell
Current Market Cap: $51.97M
Learn more about CELU stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue